Dr. Anand Madan, MD

Dr. Madan practices at Sutter Roseville Endoscopy Center in Roseville, California.

Dr. Madan's NPI, 1366418006, was assigned on February 23, 2006. Dr. Madan graduated from Government Medical College Patiala in 1994. Dr. Madan's California license number on file is A93947.

Dr. Madan's primary practice is Sutter Roseville Endoscopy Center, at 4 Medical Plaza Drive, Suite 210, Roseville, CA 95661. The practice phone is (916) 773-8780.

Dr. Madan's primary practice is Sutter Roseville Endoscopy Center in Roseville, California. Dr. Madan is also affiliated with Sutter Roseville Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Madan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Madan practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Madan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Madan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Madan's licenses on file in 4 states: California, Texas, Kentucky and Illinois.

Dmand AI lists acid reflux, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding, gastrointestinal inflammation, hemorrhoids and hepatitis c among the conditions Dr. Madan treats.

CMS data shows 798 Medicare services from Dr. Madan across 13 procedure codes in 2024, for 345 Medicare patients. Medicare paid $84,546 for them.

CMS counts 345 Medicare patients who saw Dr. Madan in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Madan's median patient age at 64, with 53% women.

In 2024, Dr. Madan wrote 1,020 Medicare Part D claims for 485 patients. 83% of them were for generic drugs. CMS names the drug for 894 of them, across 14 drugs with 11 or more claims each, at $71,898 in total drug cost. In 2023, CMS named 915 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Madan for performance year 2024, reported as part of a group. Dr. Madan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Madan as offering telehealth. CMS counts 160 procedures of colonoscopy by Dr. Madan, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Madan, published from 2008 to 2011. Dr. Madan's most frequent co-authors are Mary Elizabeth Elizabeth Hartnett, MD, Joseph P. Heitzman, DO and Shiro Urayama, MD.

CMS Open Payments shows 1,538 general payments to Dr. Madan from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Abbvie Inc. paid the most, $7,983.

Dr. Madan graduated from Government Medical College Patiala in 1994.

Dr. Madan is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.